Your browser doesn't support javascript.
loading
Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature review.
Wang, Shi-Xuan; Wang, Fang; Tu, Ye-Chao; Zhou, Yu-Lan; Tu, Song-Tao; Wang, Jie-Yu; Lv, Ke-Bing; Li, Fei.
Afiliação
  • Wang SX; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wang F; Jiangxi Clinical Research Center for Hematologic Disease, Nanchang, China.
  • Tu YC; Institute of Lymphoma and Myeloma, Nanchang University, Nanchang, China.
  • Zhou YL; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Tu ST; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wang JY; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Lv KB; Jiangxi Clinical Research Center for Hematologic Disease, Nanchang, China.
  • Li F; Institute of Lymphoma and Myeloma, Nanchang University, Nanchang, China.
Ann Hematol ; 103(10): 4319-4323, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39105740
ABSTRACT
Chronic neutrophil leukemia (CNL) is a rare and life-threatening disease. Cases of CNL combined with lymphoma are rare. Here, we report a case of CNL with T-acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) in a 28-year-old male. After a regimen of ruxolitinib, VICLP (Vincristine, Idarubicin, Cyclophosphamide, Prednisone, Peg-asparaginase) regimen, high-dose cytarabine, and methotrexate regimens, the patient's bone marrow condition partially resolved. However, when the disease relapsed four months later, despite attempts with selinexor, venetoclax, and CAG(aclarubicin hydrochloride, Algocytidine, Granulocyte Stimulating Factor) chemotherapy, the leukocytes and peripheral blood primitive cells reduced, but the bone marrow did not achieve remission. This pathogenesis may be related to microenvironmental immune escape under prolonged inflammatory stimulation and gene disruption affecting protein function due to colony-stimulating factor 3 receptor gene (CSF3R) mutations. For this type of disease, early intervention may delay disease progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Neutrofílica Crônica / Protocolos de Quimioterapia Combinada Antineoplásica Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Neutrofílica Crônica / Protocolos de Quimioterapia Combinada Antineoplásica Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article